ceb has been commissioned to prepare systematic reviews (over 100 published meta-analyses) and to support development of evidence-based treatment guidelines for governmental decision making bodies, publicly funded organizations, health insurers, medical associations and pharmaceutical companies. Our methods include direct or indirect comparisons, network meta-analyses and individual patient data meta-analyses.

ceb is an independent academic institution specialized in health Technology assessments.

Full and Rapid HTA reports, preparation of submission documents

ceb is providing full and rapid HTA reports depending on the needs and requirements of health technology agencies and we can offer support in the submission process.

ceb has long-standing expertise in creating and analyzing real world evidence. We use advanced technologies that aim to minimize bias from observational study analyses. We use findings from our empirical and methodological research to inform our methods for analyzing observational data.

Routinely collected data analysis

We are experienced in the analysis of large nationwide registry data and conduct of pharmacoepidemiological studies, looking at patient important clinical outcomes, safety data, or cost-impact in health economic studies. More recently we began to use routinely collected data to design comparative and pragmatic trials for the nationwide evaluation of health care interventions in routine practice, maximizing both internal and external validity.

As an academic institution we are experienced in advising investigators and clients on scientific projects from planning the protocol and submission to data analysis and publication.

Services:

ceb has expertise and provides consultancy services on:

• Study planning and design
• Protocol development
• Research reporting and manuscript development
• Systematic literature reviews and meta-analysis
• Pharmacoepidemiological analysis with use of registry data
• Observational data and clinical trial analysis
• Pharmacoeconomic modeling and analysis
• Reporting continues along international guidelines(e.g. SPIRIT, CONSORT, PRISMA, RECORD)